Vanguard Health Care Fund Investor Shares (VGHCX) Research
For over a quarter-century, this actively managed fund has provided investors with an economical way to access a diverse range of companies operating within the global healthcare industry. Its holdings span various segments, including pharmaceutical developers, medical equipment manufacturers, and groundbreaking research institutions. Compared to other healthcare-focused funds, it generally boasts broader international exposure and tends to have a more stable portfolio with less frequent trading. However, a key consideration for investors is its specialized concentration, as all investments are exclusively confined to the healthcare sector. Given that yearly performance can fluctuate considerably, this fund is best suited as a supplementary component within a broader, well-rounded investment portfolio, especially for those with a long-term outlook.
Market snapshot
- Symbol
- VGHCX
- Price
- $192.76
- Day change
- -0.50%
- Market cap
- $36.8B
- 52-week range
- 167-212.65
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- MFS Institutional International Equity Fund (MIEIX)
- T. Rowe Price Equity Index 500 Fund (PREIX)
- T. Rowe Price Capital Appreciation Fund (PRWCX)
- American Funds 2050 Target Date Retirement Fund (RBHEX)
- T. Rowe Price Mid-Cap Growth Fund (RRMGX)
- T. Rowe Price Value Fund (TRVLX)
- Vanguard Mid-Cap Growth ETF (VOT)
- Vanguard Target Retirement Income Fund (VTINX)
Open Vanguard Health Care Fund Investor Shares (VGHCX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.